| M&G (LUX) JAPAN LARGE CAP OPPORTUNITIES FUND EUR A ACC | RVI JAPÓN | 41,61% | · | · | · |
| MIRAE ASSET ESG ASIA GREAT CONSUMER EQUITY FUND R EUR CAP | RVI CONSUMO | 41,59% | 46,99% | -6,51% | · |
| AMUNDI MSCI EM LATIN AMERICA UCITS ETF USD CAP | RVI LATINOAMÉRICA | 41,58% | 39,11% | 69,32% | · |
| BNP PARIBAS DISRUPTIVE TECHNOLOGY N CAP | RVI TECNOLOGÍA | 41,58% | 85,32% | 93,09% | 487,24% |
| BNP PARIBAS JAPAN EQUITY CLASSIC DIS | RVI JAPÓN | 41,58% | 64,25% | 59,02% | 96,66% |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 41,58% | 16,54% | -33,74% | · |
| COMGEST GROWTH EMERGING MARKETS EUR DIS | RVI EMERGENTES CRECIMIENTO | 41,57% | 45,77% | 10,41% | 37,21% |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 41,57% | 19,97% | -23,29% | · |
| ISHARES MSCI WORLD VALUE FACTOR ESG UCITS ETF USD (ACC) | RVI GLOBAL VALOR | 41,55% | 82,37% | · | · |
| JANUS HENDERSON FUND EMERGING MARKETS A2 EUR | RVI EMERGENTES | 41,55% | 64,25% | 26,77% | 78,43% |
